Skip to main content
×
×
Home

Guidelines on antipsychotics for dementia: are we losing our minds?

  • Camilla Haw (a1), Graeme Yorston (a2) and Jean Stubbs (a2)
Abstract
Aims and Method

The National Institute for Health and Clinical Excellence (NICE) and the Royal College of Psychiatrists have each issued guidance on the use of antipsychotics for behavioural and psychiatric symptoms of dementia (BPSD). We sent all old age psychiatrists an anonymous questionnaire asking for their opinions on these documents and for details of their use of antipsychotics for BPSD.

Results

The response rate was 202 out of 648 (31.2%). the two documents, though similar in content provoked very different responses, with the College guidance being much more favourably received. All respondents prescribed antipsychotics for BPSD, most commonly quetiapine.

Clinical Implications

When prescribing antipsychotics for behavioural and psychiatric symptoms of dementia, psychiatrists should take both NICE and College guidelines into account and use their clinical judgement.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Guidelines on antipsychotics for dementia: are we losing our minds?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Guidelines on antipsychotics for dementia: are we losing our minds?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Guidelines on antipsychotics for dementia: are we losing our minds?
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Alanen, H.-M., Finne-Soveri, H., Noro, A., et al (2006) Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. International Journal of Geriatric Psychiatry, 21, 288295.
Alldred, D. P., Petty, D.R., Bowie, P., et al (2007) Antipsychotic prescribing patterns in care homes and relationship with dementia. Psychiatric Bulletin, 31, 329332.
Anonymous (2007) Lawyers claim ‘concession’ over prescribing for Alzheimer's. BMJ, 335, 11.
Committee on Safety of Medicines (2004) Atypical Anti-psychotic Drugs and Stroke: Message from Gordon Duff, Chairman, Committee on Safety of Medicines (CEM/CMO/2004/1). Medicines and Healthcare Products Regulatory Agency.
Gill, S. S., Rochon, P. A., Herrmann, N., et al (2005) Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ, 330, 445450.
Gill, S. S., Bronskill, S. E., Normand, S. L. T., et al (2007) Antipsychotic drug use and mortality in older adults with dementia. Annals of Internal Medicine, 146, 775786.
Hagen, B., Esther, C. A., Ikuta, R., et al (2005) Antipsychotics drug use in Canadian long-term care facilities: prevalence and patterns following resident relocation. International Psychogeriatrics, 17, 179193.
Lee, P. E., Gill, S. S., Freedman, M., et al (2004) Atypical antipsychotic drugs in the treatment of behvioural and psychological symptoms of dementia: systematic review. BMJ, 329, 7579.
National Collaborating Centre for Mental Health (2006) Dementia. Supporting People with Dementia and their Carers in Health and Social Care. NICE (http://www.nice.org.uk/Guidance/CG42).
Rochan, P. A., Stukel, T. A., Bronskill, S. E., et al (2007) Variations in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167, 676683.
Royal College of Psychiatrists (2005) Atypical Antipsychotics and Behavioural and Psychiatric Symptoms of Dementia. Royal College of Psychiatrists (http://www.rcpsych.ac.uk/PDF/BPSD.pdf).
Schneider, L. S., Dagerman, K. S. & Insel, P. (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 19341943.
Snowdon, J., Day, S. & Baker, W. (2005) Why and how antipsychotic drugs are used in 40 Sydney nursing homes. International Journal of Geriatric Psychiatry, 20, 11461152.
Trifirò, G., Verhamme, K. M. C., Ziere, G., et al (2007) All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538544.
Wang, P. S., Schneeweiss, S., Avorn, J., et al (2005) Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New England Journal of Medicine, 353, 23352341.
Working Group for the Faculty of the Psychiatry of Old Age of the Royal College of Psychiatrists, Royal College of General Practitioners, British Geriatrics Society & Alzheimer's Society (2004) Guidance for the management of behavioural and psychiatric symptoms in dementia and the treatment of psychosis in people with history of stroke/TIA. Royal College of Psychiatrists.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 9 *
Loading metrics...

Abstract views

Total abstract views: 62 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd June 2018. This data will be updated every 24 hours.

Guidelines on antipsychotics for dementia: are we losing our minds?

  • Camilla Haw (a1), Graeme Yorston (a2) and Jean Stubbs (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *